HopeStage
Back to all studies
RecruitingNCT06221358

Genetic patterns and stimulant treatment response in young people with ADHD

About this titleRead the official source — NCT06221358
Observational studyAges 6–24Canada
The study in practice

Understand this study

Who could participate?

This study is for people with ADHD. Listed age limits: 6 years to 24 years. Other eligibility criteria apply.

Listed locations
CalgarySee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 1, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
400
Sponsor
University of Calgary
Sponsor type
University
Study type
Observational
Intervention type
Interview / survey / observational
Locations
Canada
Age range
From 6 Years to 24 Years
Official registry ID
NCT06221358
Official title
Show the full official title

Pharmacogenomics of Stimulant Treatment Response in Children and Adolescents With Attention-Deficit/ Hyperactivity Disorder

Recruitment & locations

Currently recruiting

Calgary

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Calgary, a university.

Who can participate?

This study is for people with ADHD. Listed age limits: 6 years to 24 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies